10:21 AM EST - Avivagen Inc. : And Mimi’s Rock Corp. announced a Joint Venture agreement focused on the online sale of nutritional supplements for cats and dogs. Under the terms of the agreement, Avivagen will supply its products that include its proprietary OxC-beta™ technology and Mimi’s Rock will market and sell the product through its state of the art e-commerce platform and online global channels. Avivagen Inc.
shares V.VIV are trading up $0.04 at $0.64.
